Mylan CEO: Generics Are Backbone of our Health-Care System

Global pharmaceutical company Mylan N.V. announced a $7.2 billion deal to acquire Meda.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.